Publication 4/15/2005

Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.

Wang L, Calcedo R, Nichols TC, Bellinger DA, Dillow A, Verma IM, Wilson JM

Blood

Publication 4/01/2005

Gene transfer into skeletal muscle using novel AAV serotypes.

Louboutin JP, Wang L, Wilson JM

The Journal Of Gene Medicine

Publication 4/01/2005

Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo.

Jennings K, Miyamae T, Traister R, Marinov A, Katakura S, Sowders D, Trapnell B, Wilson JM, Gao G, Hirsch R

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Publication 4/01/2005

Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.

Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, Cideciyan AV, Jacobson SG, Wilson JM, Bennett J

Diabetes

Publication 4/01/2005

SARS vaccine: progress and challenge.

Zhi Y, Wilson JM, Shen H

Cellular & Molecular Immunology

Publication 3/15/2005

Use of chimeric adenoviral vectors to assess capsid neutralization determinants.

Roy S, Clawson DS, Calcedo R, Lebherz C, Sanmiguel J, Wu D, Wilson JM

Virology